Analysis of patient profile and factors related to healthcare-associated infections due to multidrug-resistant bacteria in the ICU of a hospital in Southern Brazil
DOI:
https://doi.org/10.33448/rsd-v11i16.38127Keywords:
Multiple antibacterial drug resistance; Healthcare Associated Infection; Delivery of health care; Intensive care unit.Abstract
Healthcare-related infections are a worldwide concern, as they increase morbidity and mortality of hospitalized patients, especially those in intensive care units. When the etiology of these infections is a multidrug-resistant microorganism, complications in treatment are even greater, and there are limited options for management. Thus, this study analyzed the occurrence of such infections in the intensive care units of the Campos Gerais Regional University Hospital from January 2017 to December 2019 by analyzing the spreadsheets provided by the Center for Hospital Infection Control and subsequent analysis of prevalence, means and medians by Excel software with the aim of profiling the patients most susceptible to contracting these infections and to analyze the microbiological profile of the sample. As for the epidemiological profile, most cases were registered in men, people over 60 years old, and patients with comorbidities. As for the microbiological profile found, the most prevalent bacteria was Klebsiella pneumoniae, with 34 cases, followed by Staphylococcus aureus, responsible for 33 occurrences. The most frequently observed resistance mechanism was methicillin-resistant Staphylococcus aureus. We conclude that infections caused by multidrug-resistant microorganisms are a concern for professionals who work in hospitals, especially in intensive care units, and that they should pay attention to preventive measures and conscientious use of antimicrobials.
References
ANVISA (2020). Microbiologia Clínica para o Controle de Infecção Relacionada à Assistência à Saúde (1st ed., Vol. 10, p. 31-33) Anvisa.
Bassetti, M., & Righi, E. (2013). Multidrug-resistant bacteria: what is the threat? Hematology, 2013(1), 428–432. https://doi.org/10.1182/asheducation-2013.1.428
Campion, M., & Scully, G. (2018). Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. Journal of Intensive Care Medicine, 33(12), 647–655. https://doi.org/10.1177/0885066618762747
Como interpretar o novo antibiograma - CML. (n.d.). Centro de Medicina Laboratorial. Retrieved November 15, 2022, from https://cmllab.com.br/medico/noticias/como-interpretar-o-novo-antibiograma
Doyle, J., Buising, K., Thursky, K., Worth, L., & Richards, M. (2011). Epidemiology of Infections Acquired in Intensive Care Units. Seminars in Respiratory and Critical Care Medicine, 32(02), 115–138. https://doi.org/10.1055/s-0031-1275525
Fraimow, H. S., & Tsigrelis, C. (2011). Antimicrobial Resistance in the Intensive Care Unit: Mechanisms, Epidemiology, and Management of Specific Resistant Pathogens. Critical Care Clinics, 27(1), 163–205. https://doi.org/10.1016/j.ccc.2010.11.002
Hochman, B., Nahas, F. X., Filho, R. S. de O., & Ferreira, L. M. (2005). Desenhos de pesquisa. Acta Cirúrgica Brasileira, 20(2), 2–9.
https://doi.org/10.1037/met0000082
Infecções Relacionadas à Assistência à Saúde. (n.d.). Saude.curitiba.pr.gov.br. Retrieved November 15, 2022, from https://saude.curitiba.pr.gov.br/vigilancia/epidemiologica/vigilancia-de-a-a-z/12-vigilancia/221-vig.html
Kołpa, M., Wałaszek, M., Gniadek, A., Wolak, Z., & Dobroś, W. (2018). Incidence, Microbiological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland. International Journal of Environmental Research and Public Health, 15(1), 112. https://doi.org/10.3390/ijerph15010112
Litwin, A., Fedorowicz, O., & Duszynska, W. (2020). Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011–2018. International Journal of Environmental Research and Public Health, 17(19), 6943. https://doi.org/10.3390/ijerph17196943
Lorenzoni, V. V., Rubert, F. da C., Rampelotto, R. F., & Hörner, R. (2018). Increased antimicrobial resistance in Klebsiella pneumoniae from a University Hospital in Rio Grande do Sul, Brazil. Revista Da Sociedade Brasileira de Medicina Tropical, 51(5), 676–679. https://doi.org/10.1590/0037-8682-0362-2017
Magira, E. E., Islam, S., & Niederman, M. S. (2018). Multi-drug resistant organism infections in a medical ICU: Association to clinical features and impact upon outcome. Medicina Intensiva, 42(4), 225–234. https://doi.org/10.1016/j.medin.2017.07.006
Martín-Loeches, I., Diaz, E., & Vallés, J. (2014). Risks for multidrug-resistant pathogens in the ICU. Current Opinion in Critical Care, 20(5), 516–524. https://doi.org/10.1097/mcc.0000000000000124
Mitharwal, S. M., Yaddanapudi, S., Bhardwaj, N., Gautam, V., Biswal, M., & Yaddanapudi, L. (2016). Intensive care unit-acquired infections in a tertiary care hospital: An epidemiologic survey and influence on patient outcomes. American Journal of Infection Control, 44(7), e113–e117. https://doi.org/10.1016/j.ajic.2016.01.021
Myrianthefs, P. M., Kalafati, M., Samara, I., & Baltopoulos, G. J. (2004). Nosocomial Pneumonia. Critical Care Nursing Quarterly, 27(3), 241–257. https://doi.org/10.1097/00002727-200407000-00005
Petrosillo, N., Granata, G., Boyle, B., Doyle, M. M., Pinchera, B., & Taglietti, F. (2019). Preventing sepsis development in complicated urinary tract infections. Expert Review of Anti-Infective Therapy, 18(1), 47–61. https://doi.org/10.1080/14787210.2020.1700794
Riley, M. M.-S. (2019). The Rising Problem of Multidrug-Resistant Organisms in Intensive Care Units. Critical Care Nurse, 39(4), 48–55. https://doi.org/10.4037/ccn2019773
Solmaz, İ., & Kalın, B. S. (2020). Assessment of antibiotic resistance of infectious agents in patients with pneumonia in tertiary critical care unit and effect on clinical outcomes. International Journal of Clinical Practice. https://doi.org/10.1111/ijcp.13872
Su, L.-H., Chen, I-Ling., Tang, Y.-F., Lee, J.-S., & Liu, J.-W. (2020). Increased financial burdens and lengths of stay in patients with healthcare-associated infections due to multidrug-resistant bacteria in intensive care units: A propensity-matched case-control study. PLOS ONE, 15(5), e0233265. https://doi.org/10.1371/journal.pone.0233265
Trilla, A. (1994). Epidemiology of nosocomial infections in adult intensive care units. Intensive Care Medicine, 20(S3), S1–S4. https://doi.org/10.1007/bf01745243
Weiner-Lastinger, L. M., Abner, S., Edwards, J. R., Kallen, A. J., Karlsson, M., Magill, S. S., Pollock, D., See, I., Soe, M. M., Walters, M. S., & Dudeck, M. A. (2019). Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infection Control & Hospital Epidemiology, 41(1), 1–18. https://doi.org/10.1017/ice.2019.296
Wilcox, M. H., & Dryden, M. (2021). Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections. Journal of Antimicrobial Chemotherapy, 76(Supplement_4), iv2–iv8. https://doi.org/10.1093/jac/dkab350
Zaragoza, R., Ramírez, P., & López-Pueyo, M. J. (2014). Infección nosocomial en las unidades de cuidados intensivos. Enfermedades Infecciosas Y Microbiología Clínica, 32(5), 320–327. https://doi.org/10.1016/j.eimc.2014.02.006
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Celine Iris Meijerink; Felipe Câncio Nascimento; Renato Mandalozzo Tebcherani; Laura Bazzi Longo; Carmen Antônia Sanches Ito; Larissa Bail; Maria Dagmar da Rocha Gaspar; Elisangela Gueiber Montes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
